JP3E Holdings Inc. announced a $19.21 million common stock warrant program, issuing warrants for nearly 2 billion shares at $0.0098 each to CEO John K. Park and board members Henry Ji and Stephen Ma. This move aims to strengthen long-term alignment between the company's leadership and shareholders as JP3E advances its growth and capital strategies. The warrants are fully vested and immediately exercisable, reflecting significant equity stakes for the leadership team but not guaranteeing future ownership percentages after additional financings.
JP3E Holdings announced a $19.21 million common stock warrant program. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 08, 2026 18:43 WIB: Out of 150 priced US tech stocks, 41 rose and 99 fell. Credo Technology Group Holding Ltd (CRDO) traded at USD 214.39, down 2.55%, with a typical hold time of 22 days and Pluang order activity showing 44% sell and 56% buy. Entegris Inc (ENTG) was priced at USD 162.11, down 2.53%, with a typical hold time of 41 days. Teradyne, Inc. (TER) traded at USD 401.50, down 2.50%, with a typical hold time of 37 days and Pluang order activity showing 6% sell and 94% buy.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
